| 1 |
34672113 | Clinical and Preclinical Evidence for Roles of Soluble Epoxide Hydrolase in Osteoarthritis Knee Pain. | 2022 Apr |
3 |
| 2 |
34873674 | A Double-Blind, Randomized, Placebo-Controlled Trial of Soluble Epoxide Hydrolase Inhibition in Patients with Aneurysmal Subarachnoid Hemorrhage. | 2022 Jun |
2 |
| 3 |
33369424 | Discovery of Soluble Epoxide Hydrolase Inhibitors from Chemical Synthesis and Natural Products. | 2021 Jan 14 |
1 |
| 4 |
33583202 | Treatment of Primary Aldosteronism Increases Plasma Epoxyeicosatrienoic Acids. | 2021 Apr |
3 |
| 5 |
34639055 | Epoxyeicosatrienoic Acids and Fibrosis: Recent Insights for the Novel Therapeutic Strategies. | 2021 Oct 3 |
1 |
| 6 |
32400048 | Soluble epoxide hydrolase inhibitor, TPPU, increases regulatory T cells pathway in an arthritis model. | 2020 Jul |
2 |
| 7 |
30885203 | Altered bioavailability of epoxyeicosatrienoic acids is associated with conduit artery endothelial dysfunction in type 2 diabetic patients. | 2019 Mar 18 |
3 |
| 8 |
31306370 | Role of Cytochrome p450 and Soluble Epoxide Hydrolase Enzymes and Their Associated Metabolites in the Pathogenesis of Diabetic Cardiomyopathy. | 2019 Sep |
3 |
| 9 |
29908721 | Time-dependent expression pattern of cytochrome P450 epoxygenases and soluble epoxide hydrolase in normal human placenta. | 2018 Aug |
2 |
| 10 |
28958841 | Effects of dronedarone, amiodarone and their active metabolites on sequential metabolism of arachidonic acid to epoxyeicosatrienoic and dihydroxyeicosatrienoic acids. | 2017 Dec 15 |
2 |
| 11 |
29055406 | The role of soluble epoxide hydrolase in preeclampsia. | 2017 Oct |
2 |
| 12 |
27184755 | EETs/sEH in diabetes and obesity-induced cardiovascular diseases. | 2016 Sep |
2 |
| 13 |
23011468 | Epoxyeicosatrienoic acid pathway in human health and diseases. | 2013 Mar |
2 |
| 14 |
23474289 | Roles of the epoxygenase CYP2J2 in the endothelium. | 2013 Dec |
2 |
| 15 |
22116511 | Reno-protective mechanisms of epoxyeicosatrienoic acids in cardiovascular disease. | 2012 Feb 1 |
2 |
| 16 |
22848834 | Anti-inflammatory effects of epoxyeicosatrienoic acids. | 2012 |
2 |
| 17 |
21519968 | Regulation of forskolin-induced cAMP production by cytochrome P450 epoxygenase metabolites of arachidonic acid in HEK293 cells. | 2011 Oct |
2 |
| 18 |
19891972 | Cytochrome P450 epoxygenases, soluble epoxide hydrolase, and the regulation of cardiovascular inflammation. | 2010 Feb |
2 |
| 19 |
20093140 | Effect of cytochrome P450 polymorphism on arachidonic acid metabolism and their impact on cardiovascular diseases. | 2010 Mar |
2 |
| 20 |
20631410 | Red blood cells (RBCs), epoxyeicosatrienoic acids (EETs) and adenosine triphosphate (ATP). | 2010 May-Jun |
2 |
| 21 |
20733953 | Epoxyeicosatrienoic acids and soluble epoxide hydrolase: potential therapeutic targets for inflammation and its induced carcinogenesis. | 2010 Jul 22 |
2 |
| 22 |
21081214 | Vascular pharmacology of epoxyeicosatrienoic acids. | 2010 |
2 |
| 23 |
18952572 | Arachidonic acid cytochrome P450 epoxygenase pathway. | 2009 Apr |
2 |
| 24 |
16987999 | Action of epoxyeicosatrienoic acids on cellular function. | 2007 Mar |
2 |
| 25 |
17431031 | Cytochrome P450 eicosanoids are activators of peroxisome proliferator-activated receptor alpha. | 2007 Jul |
2 |
| 26 |
14636671 | Epoxyeicosatrienoic acids (EETs): metabolism and biochemical function. | 2004 Jan |
3 |